The Effects of Pain Neuroscience Education in a Spanish-Speaking Population

March 15, 2021 updated by: Aaron Hartstein, Shenandoah University
Pain Neuroscience Education (PNE) has been shown to be effective to alter beliefs and decrease pain among individuals with musculoskeletal pain. Additionally, PNE has been shown to alter beliefs among middle school children. This study plans to assess the effects of PNE within a group of Spanish-speaking individuals.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Chronic pain is a topic of discussion that is becoming increasingly prevalent among healthcare professionals. With the ever-growing opioid epidemic, there are a variety of discussions on different modes of treatment other than opioid prescription. Pain neuroscience education, or PNE, is one of these alternative treatment options. PNE focuses on a patient's understanding of pain itself and relates this to the current pain they are experiencing. PNE is often a discussion between provider and patient that utilizes a series of stories, metaphors, and examples where pain is described from a point of view that is not strictly medical. Recent literature suggests there is a lack of knowledge regarding pain in the United States, particularly in the Spanish-speaking population. This population is also less likely to seek a physician's advice for pain management. For these reasons, this study will focus on the Spanish-speaking population within the Winchester community. Due to success within prior PNE studies, this study will be conducted through a classroom lecture. The overarching purpose of this study is to examine the change in knowledge of pain in the Spanish-speaking population immediately following a PNE lecture composed of stories, metaphors, and examples about pain. Because Spanish-speaking individuals are less likely to seek out a medical provider, the study may support an additional treatment option for managing chronic pain. Not only will this provide further research to support the benefits of PNE, but there is the potential to modify a participant's perception of their own pain through this educational lecture.

Study Type

Interventional

Enrollment (Actual)

8

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Virginia
      • Winchester, Virginia, United States, 22601
        • Shenandoah University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Participants must speak Spanish at least 50% of the time at home OR Spanish must be the first language learned. Participants must also be willing to sit and listen to lecture and fill out quiz before and after.

Exclusion Criteria:

  • Any individual under the age of 18 will be excluded from the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: PNE Group
A group of Spanish-speaking individuals will listen to a translated lecture related to PNE (PNE lecture). They will fill out the R-NPQ pre and post the lecture.
Behavioral: PNE lecture
A translated (from English to Spanish) lecture on Pain Neuroscience Education

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
R-NPQ
Time Frame: Immediately post-lecture
Revised Neuroscience of Pain Questionnaire
Immediately post-lecture

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Shenandoah University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 26, 2019

Primary Completion (Actual)

March 27, 2019

Study Completion (Actual)

March 15, 2021

Study Registration Dates

First Submitted

December 20, 2018

First Submitted That Met QC Criteria

December 20, 2018

First Posted (Actual)

December 24, 2018

Study Record Updates

Last Update Posted (Actual)

March 16, 2021

Last Update Submitted That Met QC Criteria

March 15, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • ShenandoahU(2018-2019)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Clinical Trials on PNE lecture

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe